https://www.selleckchem.com/pr....oducts/l-alpha-phosp
ASGE encourages and supports the appropriate use of technologies that meet its established PIVI thresholds. In this study we investigated medication adherence of kidney transplant patients (KTPs) to an immediate-release tacrolimus (IR-T) regimen and, after conversion, to a prolonged-release tacrolimus (PR-T) regimen in routine clinical practice. This was a noninterventional, observational, multicenter Swedish study. We included adult KTPs with stable graft function, remaining on IR-T or converting from IR-T to PR-T.
Like
Comment
Share
